X

ABT

Abbott (ABT) could make a new 52-week high after upbeat Q2 results and rosier outlook

Thanks to the COVID-19 testing growth, after reporting solid second quarter results and strong outlook for fiscal 2020 last Thursday,…

Abbott Laboratories (ABT) Q2 2020 Earnings Call Transcript

Abbott Laboratories (NYSE: ABT) Q2 2020 earnings call dated July 16, 2020 Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing…

Infographic: Abbott (ABT) reports Q2 2020 earnings

Abbott Laboratories (NYSE: ABT) reported second-quarter financial results before the regular trading hours on Thursday. Revenue for the quarter fell…

Abbott Laboratories (NYSE: ABT) Q1 2020 Earnings Call Transcript

Abbott Laboratories  (ABT) Q1 2020 earnings call dated Apr. 16, 2020 Corporate Participants: Scott Leinenweber — Vice President of Investor Relations, Licensing…

A graphical representation of Abbott Laboratories (ABT) Q1 2020 earnings results

Abbott Laboratories (NYSE: ABT) reported its financial results for the quarter ended March 31, 2020 today. The company reported a…

Stock Analysis: COVID-19 testing kit gives Abbott (ABT) an edge over Boston Scientific (BSX)

When Wall Street suffered huge losses after business activity was disrupted across the country due to the COVID-19 outbreak, one…

Abbott Laboratories (NYSE: ABT) Q4 2019 Earnings Call Transcript

Abbott Laboratories  (NYSE: ABT) Q4 2019 Earnings Conference Call Jan. 22, 2020 Corporate Participants: Scott Leinenweber — Vice President of Investor Relations, Licensing…

Abbott Laboratories (ABT) reports in-line earnings for Q4; guides FY20

Abbott Laboratories (NYSE: ABT) reported a marked increase in fourth-quarter earnings as the drugmaker’s strong product portfolio boosted sales in…

Abbott Laboratories (ABT) reports in-line earnings for Q3; sales miss view

Abbott Laboratories’ (NYSE: ABT) third quarter 2019 earnings came in line with the market’s projections, while sales missed the expectations.…